5/29/24 16:16 | 5/24/24 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Aselage Steve | NC | D | | P | 16 | 6.40 | 0 | 3 | 4 | 66 | I | | | | | | | | | | | | | | |
12/1/22 16:01 | 11/29/22 | ACER | Acer Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | MA | D | | P | 500 | 1.22 | 0 | 410 | 555 | 484 | D | | | | | | | | | | | | | | |
12/13/21 16:02 | 12/9/21 | ACER | Acer Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | MA | D | | P.m | 21 | 2.06 | 0 | 10 | 16 | 74 | D | | | | | | | | | | | | | | |
7/28/20 09:02 | 7/24/20 | ACER | Acer Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | MA | D | | P | 158 | 3.50 | 0 | 45 | 238 | 64 | D | | | | | | | | | | | | | | |
11/18/19 16:01 | 11/18/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Aselage Steve | NC | D | | P | 22 | 1.45 | 0 | 15 | 225 | 22 | D | | | | | | | | | | | | | | |
7/5/19 16:08 | 7/3/19 | ACER | Acer Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | MA | D | | P | 19 | 3.72 | 0 | 5 | 36 | 19 | D | | | | | | | | | | | | | | |
5/24/19 16:20 | 5/22/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Aselage Steve | NC | D | | P | 11 | 3.57 | 0 | 3 | 150 | 5 | D | | | | | | | | | | | | | | |
3/14/19 16:18 | 3/12/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Aselage Steve | NC | D | | P | 17 | 8.30 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
12/18/17 16:01 | 12/14/17 | ACER | Acer Therapeutics Inc. | TX | Health | Drug | Pharmaceutical Preparations | Aselage Steve | MA | D | | P | 24 | 12.00 | 0 | 2 | 17 | 14 | D | | | | | | | | | | | | | | |
6/14/17 14:40 | 6/14/17 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | CA | DO | CEO | P | 89 | 17.85 | 0 | 5 | 2 | 246 | D | | | | | | | | | | | | | | |
11/21/14 18:02 | 11/20/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | NY | DO | CEO | P.m | 85 | 8.46 | 4 | 10 | 3 | 372 | D | 335 | 46 | -36 | -29 | -8 | -10 | -23 | -8 | 5 | 21 | 64 | 62 | 213 | 128 |
12/27/13 19:59 | 8/15/13 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | NY | D | | P.d | 3 | 4.50 | 1 | 1 | 0 | 262 | D | | 75 | 40 | -1 | 19 | -18 | -6 | 6 | 3 | 21 | 58 | 183 | 73 | 87 |
5/6/08 18:16 | 4/30/08 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | CA | O | SVP,Glob | P.d | 16 | 10.37 | 33 | 2 | 6 | 29 | D | 211 | 124 | 38 | -3 | 4 | 15 | 7 | 3 | 0 | 5 | -1 | -18 | -52 | -62 |
1/3/08 18:47 | 10/31/07 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | CA | O | SVP,Glob | P.d | 15 | 6.92 | 33 | 2 | 44 | 7 | D | 242 | 124 | 98 | 44 | 41 | 28 | 4 | 2 | 1 | 9 | 2 | -2 | -24 | -53 |
5/2/07 16:31 | 4/30/07 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | CA | O | SVP,Glob | P | 14 | 6.92 | 32 | 2 | 73 | 5 | D | 177 | 33 | 2 | -13 | -4 | -7 | 1 | 0 | 0 | -2 | 7 | 8 | 69 | 120 |
11/22/06 16:41 | 10/31/06 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Aselage Steve | CA | O | SVP,Glob | P.d | 13 | 6.92 | 14 | 2 | 195 | 3 | D | 281 | 64 | 35 | 10 | 4 | 9 | 1 | -2 | 1 | 1 | -2 | 5 | 6 | 53 |
8/3/04 17:31 | 8/3/04 | CTIC | Cell Therapeutics Inc | WA | Health | Drug | Pharmaceutical Preparations | Aselage Steve | WA | O | EVP Glob | P | 21 | 5.25 | 0 | 4 | 25 | 20 | D | 66 | -51 | -46 | -38 | -28 | -18 | -1 | -1 | 1 | -12 | 9 | 19 | 83 | -44 |
2/20/04 16:03 | 2/18/04 | CTIC | Cell Therapeutics Inc | WA | Health | Drug | Pharmaceutical Preparations | Aselage Steve | WA | O | EVP,Glob | P | 54 | 9.00 | 0 | 6 | New | 6 | D | -58 | 56 | -20 | -6 | -12 | -15 | -8 | -5 | -3 | 1 | -5 | -17 | -40 | 18 |